Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 13NETWORK 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Genitourinary 1

Conditions

Wilms Tumor 1Kidney Neoplasms 1Advanced Malignant Neoplasm 1

Interventions

Radiotherapy 213Cisplatin 180Cyclophosphamide 168Doxorubicin 135Paclitaxel 125Vincristine 124Filgrastim 121Etoposide 103Carboplatin 100Methotrexate 83Gemcitabine 82Docetaxel 78Cytarabine 78Gene Expression Profiling 74Fluorouracil 74Prednisone 71Granulocyte Colony-Stimulating Factor 66Dexamethasone 66Leucovorin 62Polymerase Chain Reaction 47Immunohistochemistry 46Microarray Analysis 40Daunorubicin 38Irinotecan 37Ifosfamide 37Temozolomide 35Cetuximab 33Amplified Fragment Length Polymorphism Analysis 33Peripheral Blood Stem Cell Transplantation 32Mercaptopurine 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × NETWORK × Genetic Testing × Clear all
NCT02823652 2024-02-28

Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer

Eastern Cooperative Oncology Group

Phase NA Completed
601 enrolled 16 charts
Other neoplasm

Advanced Malignant Neoplasm

NCT00088803 2016-05-19

DNA Variations in the Gene in Young Patients With Wilms' Tumor

Children's Oncology Group

Completed
471 enrolled
Genitourinary

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡